MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
ASLN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Aslan Pharmaceuticals (ASLN) Ownership - Who owns Aslan Pharmaceuticals?

ASLAN Pharmaceuticals Ltd is a clinical-stage immunology-focused biopharmaceutical company developing innovative treatments to transform the lives of patients... Show more

Industry: #Biotechnology
#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Biotechnology
Address
3 Temasek Avenue
Phone
+65 68179598
Employees
34
Web
https://www.aslanpharma.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.7M
P/E Ratio
N/A
Total Cash
21.25M
Projected Growth
N/A
Total Debt
26.67M
Revenue
12M
Risk (Beta)
0.46
Dividend Yield
N/A
Total Cash/Share
7.51
Total Debt/Equity
N/A
Revenue/Share
5.51 USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for ASLN
A.I. Advisor
published General Information

General Information

a biotechnology company which develops immuno-oncology agents and targeted therapies

Industry Biotechnology

Profile
Details
Industry
Biotechnology
Address
3 Temasek Avenue
Phone
+65 68179598
Employees
34
Web
https://www.aslanpharma.com